Search Results - "Dodd, R.Y."

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population by Dodd, R.Y., Notari IV, E.P., Stramer, S.L.

“…BACKGROUND : There has been continuing prog‐ ress in measures to reduce the risk of transfusion‐ transmitted infection, including introduction of serologic…”
Get full text

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors by Busch, M P, Lee, L L, Satten, G A, Henrard, D R, Farzadegan, H, Nelson, K E, Read, S, Dodd, R Y, Petersen, L R

“…Almost all human immunodeficiency virus (HIV) transmission via blood or tissues that has occurred since anti-HIV screening was implemented in 1985 is traceable…”
Get more information

Real world incidence estimation methodologies used for surveillance of HIV in repeat blood donors by Crowder, L.A., Notari, E.P., Dodd, R.Y., Stramer, S.L., Steele, W.R.

Get full text

Transmission of Parasites by Blood Transfusion by Dodd, R.Y.

“…A number of parasitic diseases are known, or suspected to be transmitted by blood transfusion. Of greatest concern are malaria and Chagas' disease, but…”
Get full text

Current status of microbial contamination of blood components: summary of a conference by Klein, H.G., Dodd, R.Y., Ness, P.M., Fratantoni, J.A., Nemo, G.J.

Get full text

The impact of recipient factors on the lower‐than‐expected hemoglobin increment in transfused outpatients with hematologic diseases by Karafin, Matthew S., Bruhn, Roberta, Roubinian, Nareg H., Chowdhury, Dhuly, Qu, Lirong, Snyder, Edward L., Murphy, Edward L., Brambilla, Don, Cable, Ritchard G., Hilton, Joan F., St. Lezin, Elizabeth, Mast, A.E., Gottschall, J.L., Triulzi, D.J., Kiss, J.E., Murphy, E.L., St. Lezin, E.M., Snyder, E.L., Cable, R.G., Brambilla, D.J., Sullivan, M.T., Busch, M.P., Norris, P.J., Dodd, R.Y., Kleinman, S.H., Glynn, S.A., Malkin, K.B.

“…BACKGROUND Patients with cancer or chronic hematologic disorders frequently receive red blood cell (RBC) transfusions. Based on long‐standing assumptions, each…”
Get full text

Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors by Orton, S.L., Stramer, S.L., Dodd, R.Y.

“…BACKGROUND:  In 2003, West Nile virus (WNV) nucleic acid amplification testing (NAT) was implemented to detect potentially infected donors. Of more than 5.3…”
Get full text

Stability of serum alanine aminotransferase activity by Williams, K M, Williams, A E, Kline, L M, Dodd, R Y

“…In this study the authors examine the effects of common storage and handling procedures on serum alanine aminotransferase (ALT) levels. Clotted blood samples…”
Get more information

Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004 by Stramer, S.L., Foster, G.A., Dodd, R.Y.

“…BACKGROUND:  This study reports on the efficacy of an investigational human T‐lymphotropic virus (HTLV)‐I and ‐II lookback program in the context of differing…”
Get full text

Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV by Orton, S.L., Stramer, S.L., Dodd, R.Y., Alter, M.J.

“…BACKGROUND: In 1999, NAT of blood donations was implemented to detect “window‐period” infections. Blood donors who have confirmed NAT results positive for the…”
Get full text

Current impact of the confidential unit exclusion option by Zou, S., Notari IV, E.P., Musavi, F., Dodd, R.Y.

“…BACKGROUND: In 1986, the FDA recommended using a confidential unit exclusion (CUE) option in blood centers; this was rescinded in 1992. The American Red Cross…”
Get full text

Blood Donor Screening for Chagas Disease — United States, 2006–2007 by Stramer, S.L, Dodd, R.Y, Leiby, D.A, Herron, R.M, Mascola, L, Rosenberg, L.J, Caglioti, S, Lawaczeck, E, Sunenshine, R.H, Kuehnert, M.J, Montgomery, S, Bern, C, Moore, A, Herwaldt, B, Kun, H, Verani, J.R

“…Chagas disease, a zoonotic disease caused by the bloodborne parasite Trypanosoma cruzi, affects an estimated 11 million persons throughout much of Latin…”
Get full text

A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites by Leiby, DA, Kerr, K.L., Campos, J.M., Dodd, R.Y.

“…BACKGROUND: Platelet components contaminated with bacteria are an important source of transfusion‐associated bacterial sepsis. Estimates of contamination rates…”
Get full text

The effectiveness of the confidential unit exclusion option by Petersen, L R, Lackritz, E, Lewis, W F, Smith, D S, Herrera, G, Raimondi, V, Aberle-Grasse, J, Dodd, R Y

“…The confidential unit exclusion (CUE) option is intended to reduce human immunodeficiency virus (HIV) transmission by excluding donors newly infected with HIV…”
Get more information

Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods by Dodd, R Y, Moroff, G, Wagner, S, Dabay, M H, Dorfman, E, George, V, Ribeiro, A, Shumaker, J, Benade, L E

“…The ability of two fundamentally different photochemical procedures to inactivate model viruses in platelet suspensions was compared. Merocyanine 540 (MC 540)…”
Get more information

Reply by Nath, N., Dodd, R.Y.

Get full text

Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light by Benade, L E, Shumaker, J, Xu, Y, Chen, X, Dodd, R Y

“…It has previously been reported that 40 micrograms per mL of aminomethyltrimethylpsoralen (AMT) plus 2.4 to 7.2 J per cm2 of ultraviolet A (UVA) light…”
Get more information

Viral inactivation in platelet concentrates by Dodd, R Y

“…Although the current risk of posttransfusion infection is very low in North America and Western Europe, there continues to be considerable interest in measures…”
Get more information

How far shall we go in the predonation selection of blood donors to safeguard patients for blood-transfusion-related infections?

Get more information

Western Blot Advisory by Dock, N.L., Kleinman, S.H., Rayfield, M.A., Schable, C.A., Williams, A.E., Dodd, R.Y.

Get full text